Peripheral neuropathy: why only some mutations cause disease
Long nerves in our limbs may be particularly sensitive to even slight interference from particular mutations. If researchers can find ways to target and block the mRNA or protein made from the mutant genes, it might be possible to treat inherited peripheral neuropathies
360° Perspective Analysis
Deep-dive into Geography, Polity, Economy, History, Environment & Social dimensions — AI-powered, on-demand
Context
Recent research highlights the complexity of Inherited Peripheral Neuropathies (IPN), genetic disorders affecting the peripheral nervous system. While mutations in over 100 genes, including those coding for aminoacyl-tRNA synthetases (ARS), are linked to IPN, scientists are exploring why only specific mutations within these genes trigger the disease. This underscores the intricacies of genetic expression and its translation into physiological disorders.
UPSC Perspectives
Health & Biotech
From a biological perspective, this article touches upon fundamental concepts of genetics relevant to the UPSC syllabus. Inherited Peripheral Neuropathies (IPN) are a group of genetic disorders that cause damage to the peripheral nerves, which transmit signals between the central nervous system and the rest of the body. The article notes that mutations in genes coding for aminoacyl-tRNA synthetases (ARS) are a known cause. ARS are crucial enzymes involved in protein synthesis, specifically attaching the correct amino acid to its corresponding tRNA molecule. Understanding why only certain mutations in these critical genes lead to a diseased state, while others do not, is a key area of study in molecular genetics. This highlights the difference between a genotype (the genetic makeup) and a phenotype (the observable characteristics or disease state). For UPSC Prelims, aspirants should be familiar with basic genetic terms like mutation, gene expression, and the role of RNA and enzymes in biological processes, as questions often test foundational science knowledge.
Scientific Research
The study of IPN illustrates the challenges in precision medicine and genetic diagnostics. The fact that only specific mutations within a known disease-causing gene actually result in the disorder complicates diagnosis and genetic counseling. It suggests that the manifestation of genetic diseases is not always a simple 'on/off' switch but may involve complex interactions, perhaps including environmental factors or other genetic modifiers (epistasis). This complexity necessitates advanced genomic sequencing and functional studies to pinpoint pathogenic (disease-causing) variants from benign ones. The supports research into such genetic disorders to improve diagnostic accuracy and potentially develop targeted therapies. In the context of GS Paper 3, understanding the trajectory of biotechnology research—from identifying a mutated gene to understanding its precise functional impact—is essential for answering questions on the applications and implications of modern science.
Social
The social impact of rare genetic diseases like IPN is significant, affecting approximately 1 in 2,500 individuals. The physical manifestations, such as high foot arches, muscle weakness, and loss of sensation, can lead to severe disability and affect a person's quality of life and economic productivity. While the aims to provide treatment and support for specific conditions, many genetic neuropathies currently lack definitive cures, relying mainly on supportive care and physical therapy. This highlights the ongoing need for public health initiatives to support individuals with chronic, inherited conditions, including access to specialized care, assistive devices, and disability rights frameworks. The intersection of scientific discovery with public health policy and disability rights is a critical area for UPSC Mains, focusing on the state's role in providing equitable healthcare.